期刊文献+

截短侧耳素的萃取及结晶 被引量:1

Extraction and Crystallization of Pleuromutilin
下载PDF
导出
摘要 研究截短侧耳素的萃取和结晶。截短侧耳素闪蒸粉分别用甲醇、乙醇和K酮在20℃、40℃和60℃条件下萃取,萃取时间60min,比较萃取率;60℃的K酮饱和溶液,分别降温至50℃、45℃和40℃,加入晶种保温3h,然后以5~8℃/h的速度降温至0℃,然后保温2h,离心获得晶体,50℃干燥1h,获得截短侧耳素粉,分析干燥失重、含量、杂质和收率。K酮在60℃时的萃取率最高,均值为92%;40℃加入晶种保温3h获得产品收率最高95.01%。K酮为更加理想的截短侧耳素萃取剂,萃取温度60℃,晶体成长的第一过程选择40℃。 Research extraction and crystallization of pleuromutilin. Pleuromutilin flash powder with methanol, ethanol and K ketone was extracted at 20 ℃, 40 ℃ and 60 ℃, extraction time 60 min, compared extraction rate. K ketone saturated solution at 60 ℃ was cooled to 50 ℃, 45 ℃ and 40℃, respectively, with addition of crystal warmed for 3h, and then cooled to 0 ℃ at the speed of 5-8℃ per 1 hour, then warmed for 2h, centrifugated for crystal, dryed for lh at 50 ℃, obtained pleuromutilin powder, loss on drying, content analysis, impurity and yield. K ketone extraction rate is the highest at 60 ℃, average is 92%. At 40℃ by adding crystal seeds obtained the highest yield products 95.01% for 3h. K ketone as truncated ear is more ideal element extractant, extraction tem- perature 60℃, crystal growth process at 40℃ first choice.
出处 《中国动物保健》 2013年第7期27-28,34,共3页 China Animal Health
关键词 截短侧耳素 萃取 结晶 pleuromutilin extraction crystallization
  • 相关文献

参考文献3

二级参考文献46

  • 1Kavanagh F, Hervey A, Robbins W J. Antibiotic substances from Basidiomycetes: Ⅷ. Pleurotus multilus (Fr.) Sacc. and Pleurotus passeckerianus Pilat[J]. Proc Natl Acad Sci, 1951, 37(9): 570 -574.
  • 2Kavanagh F, Hervey A, Robbins W J. Antibiotic substances from Basidiomycetes: Ⅸ. Drosophila subtarata (Batsch Ex Fr. ) Quel[J]. Proc Nail Acad Sci, 1952, 38(7): 555 - 560.
  • 3Phillips 0 A, Sharaf L H. Pleuromutilin antibacterial agents: patent review 2001-2006[J]. Expert Opin TherPat, 2007, 17(4): 429-435.
  • 4Long K S, Hansen L H, Jakobsen L, et al. Interaction of pleuromutilin derivatives with the ribosomal peptidyl transferase center[J]. Antimicrob Agents Chemother, 2006, 50(4):1458 - 1462.
  • 5Poulsen S M, Karlsson M, Johansson L B, et al. The pleuromutilin drugs tiamulin and valnemulin bind to the RNA at the peptidyl transferase centre on the ribosome[J]. Mol Microbiol, 2001, 41(5): 1091 - 1099.
  • 6Baggetto L G, Dong M, Bernaud J, et al. In vitro and in vivo reversal of cancer cell muhidrug resistance by the semi- synthetic antibiotic tiamulin[J]. Biochem Pharmacol, 1998, 56(9): 1219 - 1228.
  • 7Hannan P C T, Windsor H M, Ripley P H. In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor ), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasna hyopneumon/ae[J]. Res Vet Sci, 1997, 36(2): 157-160.
  • 8Karlsson M, Gunnarsson A, Franklin A. Susceptibility to pleuromutilins in Brachyspira (Serpulina) hyodysenteriae[J]. Anim Health Res Rev, 2001, 2(1): 59-65.
  • 9Zullo A, Hassan C, Eramo A, et al. Helicobacter pylori therapy: what is coming? [J]. Expert Opin Ther Pat, 2006, 16(8): 1107-1112.
  • 10Heilmann C, Jensen L, Jensen J S, et al.Treatment of - tant mycoplasma infection in immunocompromised patients with a new pleuromutilin antibiotic[J]. J Infect, 2001, 43 (4): 234 - 238.

共引文献59

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部